| ID | Sequence | Length | GC content |
|---|---|---|---|
| ACUCCGCCUUCCACGUGCACCCACUGCCUCUUCCCUUCUCGCUUGGGAA… | 410 nt | 0.5293 | |
| ACUCCGCCUUCCACGUGCACCCACUGCCUCUUCCCUUCUCGCUUGGGAA… | 407 nt | 0.5283 |
Enables zinc ion binding activity. Involved in several processes, including cellular response to cadmium ion; cellular response to copper ion; and cellular response to zinc ion. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
A study in human HT-29 colorectal adenocarcinoma cells demonstrated that the MT1G was induced 17.61-fold by arsenic trioxide exposure, with dose-dependent upregulation confirmed by qRT-PCR [Kazuta et al. DOI:10.1016/J.Legalmed.2026.102774]. In a separate human study, the MT1G was identified as a differentially expressed factor in the serum of sepsis patients compared to healthy volunteers, with its mRNA expression pattern consistent with corresponding protein levels [Wang et al. DOI:10.2147/IDR.S380137]. A study in mice demonstrated that the MT1G was commonly up-regulated more than 2-fold in liver tissue after in vivo exposure to α-particles and γ-rays, a characteristic response to radiation compared to hepatotoxicants [Roudkenar et al. DOI:10.1269/jrr.07078].